Showing results (421-430 of 1,350) with videos related to
Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|January 17, 2019
A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced DietFrancesco Muntoni, Bina Tejura, Stefan Spinty, et al.Clinical Pharmacology in Drug Development|February 8, 2019
A Cocktail Interaction Study Evaluating the Drug-Drug Interaction Potential of the Perpetrator Drug ASP8477 at Multiple Ascending Dose LevelsNicoline Treijtel, Christiane Collins, Michel van Bruijnsvoort, et al.Clinical Pharmacology in Drug Development|February 14, 2019
Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy VolunteersZancong Shen, Caroline A Lee, Kathleen Wallach, et al.Clinical Pharmacology in Drug Development|December 28, 2018
Quantitative Assessment of the Effect of Chronic Kidney Disease on the Nonrenal Clearance of 10 Drugs After Intravenous AdministrationPeter H Hinderling, Yichao YuClinical Pharmacology in Drug Development|December 1, 2018
Pharmacokinetic Interaction Study Between Saxagliptin and Omeprazole, Famotidine, or Magnesium and Aluminum Hydroxides Plus Simethicone in Healthy Subjects: An Open-Label Randomized Crossover StudySong Ren, David W BoultonClinical Pharmacology in Drug Development|December 1, 2018
Effects of Rifamycin Coadministration on Bedaquiline Desmethylation in Healthy Adult VolunteersAmanda M Healan, Robert A Salata, J McLeod Griffiss, et al.Clinical Pharmacology in Drug Development|December 18, 2018
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese SubjectsHiroko Ino, Yohei Doi, Lia Liefaard, et al.Clinical Pharmacology in Drug Development|April 7, 2020
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of DaprodustatMasanori Yamada, Minori Osamura, Hirofumi Ogura, et al.Clinical Pharmacology in Drug Development|April 7, 2020
Effects of Vitamin D Receptor, Cytochrome P450 3A, and Cytochrome P450 Oxidoreductase Genetic Polymorphisms on the Pharmacokinetics of Remimazolam in Healthy Chinese VolunteersKun Hu, Qian Xiang, Zhe Wang, et al.Clinical Pharmacology in Drug Development|October 18, 2022
Safety, Pharmacokinetics, and Pharmacodynamics of CC-90001 (BMS-986360), a c-Jun N-terminal Kinase Inhibitor, in Phase 1 Studies in Healthy ParticipantsYing Ye, Allison Gaudy, Michael Thomas, et al.Pageof 135